CN105624174A - 一种促进丙酮酸分泌的基因、其提取方法和应用 - Google Patents
一种促进丙酮酸分泌的基因、其提取方法和应用 Download PDFInfo
- Publication number
- CN105624174A CN105624174A CN201610096612.4A CN201610096612A CN105624174A CN 105624174 A CN105624174 A CN 105624174A CN 201610096612 A CN201610096612 A CN 201610096612A CN 105624174 A CN105624174 A CN 105624174A
- Authority
- CN
- China
- Prior art keywords
- gene
- psac
- phosphorus
- cdna
- escherichia coli
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 33
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 title abstract description 8
- 229940107700 pyruvic acid Drugs 0.000 title abstract description 4
- 238000000605 extraction Methods 0.000 title abstract description 3
- 230000001737 promoting effect Effects 0.000 title description 2
- 230000009858 acid secretion Effects 0.000 title 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims abstract description 34
- 229910052698 phosphorus Inorganic materials 0.000 claims abstract description 34
- 239000011574 phosphorus Substances 0.000 claims abstract description 34
- 241000588724 Escherichia coli Species 0.000 claims abstract description 20
- 239000002773 nucleotide Substances 0.000 claims abstract description 5
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 5
- 238000010367 cloning Methods 0.000 claims abstract description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 108010020248 psaB subunit photosystem I Proteins 0.000 claims description 22
- 239000002299 complementary DNA Substances 0.000 claims description 21
- 241000228245 Aspergillus niger Species 0.000 claims description 11
- 241000894006 Bacteria Species 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 108020004999 messenger RNA Proteins 0.000 claims description 5
- 108700026244 Open Reading Frames Proteins 0.000 claims description 4
- 238000012163 sequencing technique Methods 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 238000004458 analytical method Methods 0.000 claims description 2
- 230000005611 electricity Effects 0.000 claims 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 2
- 238000012216 screening Methods 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 235000001014 amino acid Nutrition 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 abstract description 9
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 238000001400 expression cloning Methods 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 230000007928 solubilization Effects 0.000 abstract 1
- 238000005063 solubilization Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 12
- 239000002609 medium Substances 0.000 description 12
- 229940076788 pyruvate Drugs 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 150000007524 organic acids Chemical class 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 229940093915 gynecological organic acid Drugs 0.000 description 7
- 229910017053 inorganic salt Inorganic materials 0.000 description 7
- 235000005985 organic acids Nutrition 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 4
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 239000000174 gluconic acid Substances 0.000 description 4
- 235000012208 gluconic acid Nutrition 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 235000011054 acetic acid Nutrition 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000985513 Penicillium oxalicum Species 0.000 description 2
- 102000006010 Protein Disulfide-Isomerase Human genes 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- 229960004106 citric acid Drugs 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229960000448 lactic acid Drugs 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 229940099690 malic acid Drugs 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 229940116315 oxalic acid Drugs 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 108020003519 protein disulfide isomerase Proteins 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- DPZHKLJPVMYFCU-UHFFFAOYSA-N 2-(5-bromopyridin-2-yl)acetonitrile Chemical compound BrC1=CC=C(CC#N)N=C1 DPZHKLJPVMYFCU-UHFFFAOYSA-N 0.000 description 1
- 101150033839 4 gene Proteins 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000956177 Aspergillus kawachii IFO 4308 Species 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 102000013460 Malate Dehydrogenase Human genes 0.000 description 1
- 108010026217 Malate Dehydrogenase Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 1
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- RWYFURDDADFSHT-RBBHPAOJSA-N diane Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1.C1=C(Cl)C2=CC(=O)[C@@H]3CC3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RWYFURDDADFSHT-RBBHPAOJSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229940013688 formic acid Drugs 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229960002598 fumaric acid Drugs 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- WUJISAYEUPRJOG-UHFFFAOYSA-N molybdenum vanadium Chemical compound [V].[Mo] WUJISAYEUPRJOG-UHFFFAOYSA-N 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940095574 propionic acid Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012106 screening analysis Methods 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/38—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from Aspergillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明提出一种基因psa?C,所述基因psa?C的核苷酸序列如SEQ?ID?No.1所示。由所述的基因psa?C编码的蛋白的氨基酸序列如SEQ?ID?No.2所示。本发明还提出所述基因psa?C的提取方法和应用。本发明提供了基因psa?C的核苷酸序列;通过异源表达克隆得到的基因,利用大肠杆菌可高效产生丙酮酸;克隆得到的溶磷基因具有将难溶磷转化为有效磷的效果。
Description
技术领域
本发明属于生物技术领域,具体涉及一种促进丙酮酸分泌的基因及其应用。
背景技术
微生物在生长过程中能够分泌各种有机酸,比较常见的有机酸有琥珀酸、柠檬酸、α-酮戊二酸、苹果酸、丙酮酸、乳酸、乙酸、甲酸、丙酸、富马酸和草酸。这些有机酸具有多种作用,在农业上,能够溶解土壤无机磷提高土壤磷素的利用率,有机酸与土壤中铁、铝、钙等离子螯合,从而使难溶磷转化为有效磷,提高磷肥利用率。
丙酮酸分子式CH3COCOOH,可通过乙酰CoA和三羧酸循环实现体内糖、脂肪和氨基酸间的互相转化,在三大营养物质的代谢联系中起着重要的枢纽作用,是参与整个生物体基本代谢的中间产物之一。丙酮酸用途和广泛,可用于生产色氨酸、苯丙氨酸和维生素B的主要原料,是生物合成L-多巴的原料,也是乙烯聚合物的起始剂,是杀菌剂噻菌灵的中间体,也是一种食品用香料;丙酮酸及它生成的盐,在医药领域应用很广,用于生产镇静剂、抗氧剂、抗病毒剂、合成治疗高血压的药物等等。
微生物的溶磷机理大致分为5种:有机酸、氢质子(NH4-N供应)、磷酸酶(蛋白质)、螯合作用和氧化还原,其中产生有机酸是一种主要的溶磷方式,有机酸能与铁、铝、钙等离子螯合,从而使难溶磷转化为有效磷(唐超西,龚明波,2012,中国农业科学,45(18):3792-3800.)。
关于溶磷相关基因研究以细菌为主,其主要机制是将葡萄糖直接氧化产生葡萄糖酸(GA),其中葡萄糖酸的合成是由葡萄糖脱氢酶(GDH)和协同因子吡咯喹啉奎宁(PQQ)完成(GoldsteinAH,1999,FEMSMicrobiologyEcology,30(4):295-300.)。目前关于真菌溶磷相关基因的克隆也有报道,主要是以黑曲霉和草酸青霉为主,但其数量非常少,主要机制也不是很明确,也有报道从草酸青霉中克隆到的基因编码合成苹果酸脱氢酶在大肠杆菌中表达,分泌苹果酸、乳酸、醋酸、柠檬酸、草酸等有机酸从而使难溶磷溶解(GongMB,2014,CanadianJournalofMicrobiology,60:1-5)。
目前,在ncbi数据库中发布了真菌AspergillusnigerCBS513.88(XM_001398218.2)的全基因组序列,与本发明序列同源性都为99%,该基因编码的蛋白与AspergillusnigerCBS513.88编码的蛋白disulfideisomerase(XP_001399725.1)的蛋白同源性为100%以及AspergilluskawachiiIFO4308编码的蛋白disulfideisomerase(GAA82152.1)的蛋白同源性为99%,但未报到其具有产生丙酮酸的功能。其它报道的都为假定蛋白,没有进行功能分析。
发明内容
针对本领域存在的不足之处,本发明的目的是提出一种促进分泌丙酮酸的基因psaC。
本发明的另一目的是提出所述基因psaC的提取方法。
本发明的第三个目的是提出所述基因psaC的应用。
实现本发明上述目的技术方案为:
一种基因psaC,所述基因psaC的核苷酸序列如SEQIDNo.1所示。
一种所述的基因psaC编码的蛋白,所述蛋白的氨基酸序列如SEQIDNo.2所示。
本发明所述基因psaC的提取方法,包括步骤:
1)在难溶磷无机盐培养基上培养黑曲霉菌H1(AspergillusnigerH1),从培养的黑曲霉菌H1基因组中提取总RNA,再从总RNA中纯化出mRNA,用引物5'-(GA)10ACTAGTCTCGAG(T)18V-3’(V:AorCorG扩增,合成cDNA第一链;
2)cDNA第一链以5'-AAGCTTAAGGGTATCAACGCAGAGTAC-3为引物,通过LD-PCR合成双链cDNA,
3)将cDNA序列连接到pBluescriptSKII(+)上,连接产物电转化到大肠杆菌上,通过难溶磷培养基筛选具有溶磷透明圈的转化子;
4)筛选出的转化子进行转接培养,筛选克隆子进行测序分析,得到全长为1007bp的cDNA序列,利用DNAMAN分析其基因开放阅读框为208个氨基酸。
其中,步骤1)可用RNAisoplus试剂盒提取总RNA,用OligotexmRNAMiniKit试剂盒从总RNA中纯化mRNA。
PCR反应条件可以为:95℃预变性1min;95℃变性15s;65℃退火30s,68℃延伸6min,30cycles4℃forever。
其中,步骤3)所述电转化的条件为:每50μL大肠杆菌感受态细胞施加电量25μF,电击的电压为1.5KV。
本发明还提出含有本发明所述基因的载体。
其中,所述载体可以为表达载体pBluescriptSKII(+)。
含有本发明所述基因的工程菌。
其中,所述工程菌为大肠杆菌。所述大肠杆菌可以为E.coliHST08。
本发明还提出所述基因的应用,即,基因psaC在生产丙酮酸中的应用。
以及,基因psaC在溶解无机难溶磷中的应用。
本发明从黑曲霉H1中克隆溶磷基因,其编码的蛋白导入大肠杆菌中,在难溶磷无机盐培养基中培养36h时,促进大肠杆菌分泌丙酮酸,含量达到1706μg/mL,溶液的pH值从6.45降到3.34,释放的可溶磷含量为0.18mg/mL。
本发明的有益效果在于:
1、本发明首先提供了溶磷基因psaC的核苷酸序列;
2、本发明通过异源表达克隆得到的溶磷基因,利用大肠杆菌可高效产生丙酮酸;
3、本发明通过异源表达克隆到的溶磷基因具有将难溶磷转化为有效磷的效果。
附图说明
图1为实施例1黑曲霉菌H1在难溶磷无机盐培养基上培养3d的形态。
图2为实施例1黑曲霉菌H1的总RNA图。
图3为实施例2中携带溶磷基因的克隆子。
图4为工程菌培养不同溶液pH值的变化。
图5为工程菌培养不同溶液可溶磷含量的变化。
图6为实施例5大肠杆菌产丙酮酸的液相色谱图。
图7为5200mg/L的丙酮酸标准样品液相色谱图。
具体实施方式
下面结合附图和实施例,对本发明的具体实施方式作进一步详细描述。本领域技术人员应当知晓,本发明的范围不仅限于特定的实施方案,在不脱离本发明的精神下可以进行各种修饰和改变。
实施例中,大肠杆菌菌种购自大肠杆菌菌种购自生工生物工程(上海)股份有限公司。
如未特别说明,具体实施方式中所采用的手段均为本领域常规的技术手段。
实施例1黑曲霉菌的cDNA全长文库构建
实验所用菌株黑曲霉H1为中国农业科学院农业资源与农业区划研究所农业菌种保藏中心从土壤样品中筛选,在难溶磷无机盐培养基上培养3d,取0.2g左右新鲜菌丝(如图1),液氮研磨,利用RNAisoplus试剂盒提取总RNA,用OligotexmRNAMiniKit试剂盒从总RNA中纯化出mRNA。每个离心管加入2μL纯化的mRNA,1μL浓度为12μM的3’SMARTCDSPrimerIIA(5'-(GA)10ACTAGTCTCGAG(T)18V-3’(V:AorCorG)),最后用RNaseFreeH2O补足至终体积为4.5μL,使溶液充分混匀后离心,72℃水浴3min,立即转到42℃水浴2min,立即向每个离心管中加入5.5μL混合液(表1),充分混匀后离心,置于42℃水浴90min,立即放置冰上,cDNA第一链合成,产物立即进行LD-PCR或-20℃保存备用。
表1第一链合成混合液
以2μL第一链cDNA产物为模板,SMARTerIIA(5'-AAGCTTAAGGGTATCAACGCAGAGTAC-3)为引物,通过LD-PCR合成双链cDNA,反应体系见表2,PCR反应条件设定:95℃预变性1min;95℃变性15s;65℃退火30s,68℃延伸6min,30cycles4℃forever。将PCR扩增产物取3.0μL用1.0%琼脂糖凝胶中电泳检测。
表2第二链合成反应体系
利用CHROMASPIN+TE-1000纯化cDNA,去除小于500bp的片段,沉淀回收cDNA片段。用T4DNA聚合酶补平cDNA的末端后,在其两端连接EcoRI/XhoI定向接头,并用EcoRI/XhoI对接头进行酶切,得到5’端为EcoRI、3’端为HindIII酶切位点的双黏性末端cDNA。纯化后的cDNA片段通过T4DNA连接酶连接到经过EcoRI/XhoI双酶切的pBluescriptSKII(+)载体上,将连接产物电转化到宿主菌E.coliHST08,具体操作如下:
1)超低温冰箱中取出E.coliHST08感受态细胞(50μL)置于冰中融化。
2)E.coliHST08感受态细胞完全融化后立即加入2μL重组质粒,并均匀。
3)将混匀液立即加到预冷的0.1cm冲击槽内。
4)电转化条件为1.5KV,200Ω,25μF,电转化结束后迅速将离心管置于冰中冷却,并加入1mLLB培养基。
5)将加入LB的离心管于37℃200r/min振荡培养1h。
取10μL转化液涂布LB培养基上过夜培养,随机挑取转化后的克隆子,在LB培养液中培养过夜,提取质粒,将质粒用EcoRI和XhoI酶切质粒,检测连接片段的大小,结果显示插入大小为600bp~3kb(图2)。将转化后的宿主菌接种在2mLLB液体培养基中37℃温浴2h,得到初级cDNA文库,4℃保存备用。
实施例2基因的筛选及生物信息学分析
将含有文库细菌的培养液稀释涂布到含有氨苄青霉素(100μg/mL)难溶磷培养基上,37℃培养3-4d,观察是否有溶磷透明圈产生,以大肠杆菌E.coliHST08为受体菌,将产生透明圈的转化子转接培养,如图3所示,一共有169个克隆子在难溶磷培养基上出现透明圈,其中该克隆子的效果相对较好,将该克隆子提质粒测序得到DNA的序列,该cDNA序列全长1007bp,在NCBI上通过Blast进行比对分析,并利用DNAMAN6.0进行开放阅读框分析,该基因开放阅读框为208个氨基酸,标记为基因psaC,并将翻译蛋白在PDB数据库上比对分析。
实施例3基因psaC对难溶磷无机盐培养液pH的影响
将上述筛选出的克隆子接种到50mL带抗性(氨苄100ppm)的难溶磷无机盐培养液的150mL三角瓶中,培养基配方为:葡萄糖10g,(NH4)2SO40.5g,NaCl0.3g,KCl0.3g,MgSO4·7H2O0.3g,FeSO4·7H2O0.03g,MnSO4·4H2O0.03g,Ca3(PO4)210.0g,蒸馏水1000mL,pH值为6.45。
以大肠杆菌E.coliHST08为受体菌,接种含有基因的转化子和不含目的基因(只带有pBluescriptSKII(+)质粒)的大肠杆菌各1mL,37℃,200r/min培养,设置三个重复,在2h、4h、8h、12h、16h、20h、24h和36h测定溶液的pH值,在2h时,pH值开始明显下降,为6.0,随着时间的延长,接种转化子的溶液pH值迅速降低,在20h时,溶液pH值趋于稳定,在36h时,降到最低值达到3.34(图4),而不携带基因的大肠杆菌溶液pH最终降到5.6左右时不再变化。
实施例4基因psaC对难溶磷无机盐培养液难溶磷的溶解
实验操作同实验3,在4、8、12、16、24、36h时,将溶液离心取上清,105~110℃干燥后的磷酸二氢钾作为标样,用钒钼黄比色法测定可溶磷含量。溶液可溶磷的含量变化与溶液pH值成负相关,溶液pH值越低,释放的可溶磷含量越高,在36h溶液中可溶磷含量升到最高,达到0.18mg/mL(图5),不携带该基因的大肠杆菌培养液可溶磷含量没有变化。
实施例5基因psaC对大肠杆菌E.coliHST08产酸的影响
实验设计如同实施例3,在36h取出溶液上清,20000rpm离心,过滤后通过美国戴安公司ICS-3000液相色谱仪分析溶液中有机酸的种类和含量。采用的安捷伦的1100液相色谱,色谱柱为C18柱5μm(4×250mm),进柱体积10μL,流动相:甲醇,0.01mol/LKH2PO4缓冲液(pH2.80),淋洗液梯度洗脱程序为0~5min,100%磷酸缓冲液(pH2.80),5~15min,95%的磷酸缓冲液(pH2.80)和5%的甲醇,15~25min,55%的磷酸缓冲液(pH2.80)和45%的甲醇,25~30min,95%的磷酸缓冲液(pH2.80)和5%的甲醇,检测波长215nm,流速0.7ml/min,柱温25℃。培养36h后,不含psaC的E.coliHST08只产生少量乙酸,含量为18.5μg/mL,而含psaC的E.coliHST08分泌大量丙酮酸,液相色谱图显示,在4.874分钟时峰面积为11577.4,对应丙酮酸含量达到为1706μg/mL(图4,图5)。
虽然,上文中已经用一般性说明及具体实施方案对本发明作了详尽的描述,但在本发明基础上,可以对之作一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。
Claims (9)
1.一种基因psaC,其特征在于,所述基因psaC的核苷酸序列如SEQIDNo.1所示。
2.一种由权利要求1所述的基因psaC编码的蛋白,其特征在于,所述蛋白的氨基酸序列如SEQIDNo.2所示。
3.权利要求1所述基因psaC的提取方法,其特征在于,包括步骤:
1)在难溶磷无机盐培养基上培养黑曲霉菌H1(AspergillusnigerH1),从培养的黑曲霉菌H1基因组中提取总RNA,再从总RNA中纯化出mRNA,用引物5'-(GA)10ACTAGTCTCGAG(T)18V-3’(V:AorCorG扩增,合成cDNA第一链;
2)cDNA第一链以5'-AAGCTTAAGGGTATCAACGCAGAGTAC-3为引物,通过LD-PCR合成双链cDNA,
3)将cDNA序列连接到pBluescriptSKII(+)上,连接产物电转化到大肠杆菌上,通过难溶磷培养基筛选具有溶磷透明圈的转化子;
4)筛选出的转化子进行转接培养,筛选克隆子进行测序分析,得到全长为1007bp的cDNA序列,利用DNAMAN分析其基因开放阅读框为208个氨基酸。
4.根据权利要求3所述的提取方法,其特征在于,步骤3)所述电转化的条件为:每50μL大肠杆菌感受态细胞施加电量25μF,电击的电压为1.5KV。
5.含有权利要求1所述基因的载体。
6.含有权利要求1所述基因的工程菌。
7.如权利要求6所述的工程菌,其特征在于,所述工程菌为大肠杆菌。
8.基因psaC在生产丙酮酸中的应用。
9.基因psaC在溶解无机难溶磷中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610096612.4A CN105624174B (zh) | 2015-12-22 | 2016-02-22 | 一种促进丙酮酸分泌的基因、其提取方法和应用 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2015109701410 | 2015-12-22 | ||
CN201510970141 | 2015-12-22 | ||
CN201610096612.4A CN105624174B (zh) | 2015-12-22 | 2016-02-22 | 一种促进丙酮酸分泌的基因、其提取方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105624174A true CN105624174A (zh) | 2016-06-01 |
CN105624174B CN105624174B (zh) | 2019-04-19 |
Family
ID=56039518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610096612.4A Expired - Fee Related CN105624174B (zh) | 2015-12-22 | 2016-02-22 | 一种促进丙酮酸分泌的基因、其提取方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105624174B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103409436A (zh) * | 2013-08-20 | 2013-11-27 | 中国农业科学院农业资源与农业区划研究所 | 一种促进有机酸分泌的溶磷基因 |
CN103409437A (zh) * | 2013-08-20 | 2013-11-27 | 中国农业科学院农业资源与农业区划研究所 | 一种促进乙酸分泌的溶磷基因 |
-
2016
- 2016-02-22 CN CN201610096612.4A patent/CN105624174B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103409436A (zh) * | 2013-08-20 | 2013-11-27 | 中国农业科学院农业资源与农业区划研究所 | 一种促进有机酸分泌的溶磷基因 |
CN103409437A (zh) * | 2013-08-20 | 2013-11-27 | 中国农业科学院农业资源与农业区划研究所 | 一种促进乙酸分泌的溶磷基因 |
Non-Patent Citations (1)
Title |
---|
NCBI REFERENCE SEQUENCE:XP_001399725: "XP_001399725", 《NCBI》 * |
Also Published As
Publication number | Publication date |
---|---|
CN105624174B (zh) | 2019-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104611396B (zh) | 一种生产谷胱甘肽的方法 | |
CN103614386B (zh) | 盐穗木金属硫蛋白基因及其重组蛋白与应用 | |
CN102220299B (zh) | 一种阿魏酸酯酶a突变体及其用途 | |
CN102260692A (zh) | 一种八氢番茄红素脱氢酶基因及其应用 | |
CN111979168A (zh) | 一种提高乳酰-n-三糖ii产量的基因工程菌及生产方法 | |
CN107723252A (zh) | 生产巴伦西亚橘烯和诺卡酮的重组解脂耶氏酵母菌及构建方法 | |
CN107338258A (zh) | 生产β‑丙氨酸的工程菌构建及其生产β‑丙氨酸的方法 | |
CN104878024A (zh) | 一株重组大肠杆菌的构建及其合成(s)-2-羟基-3-苯基丙酸的方法 | |
CN106191084A (zh) | 一种α‑L‑鼠李糖苷酶基因的克隆、表达及应用 | |
CN114058560B (zh) | 甘氨酸的生产方法 | |
CN105462949A (zh) | 一种谷氨酸脱羧酶突变体及其制备方法和用途 | |
CN105238797B (zh) | 一种无乳链球菌的gshF基因的突变基因及其应用 | |
CN104093836A (zh) | 烃合成酶基因及其利用 | |
CN106011184A (zh) | 2-苯乙醇的非细胞合成生物学制备方法及应用 | |
CN104531637A (zh) | 一种β-葡萄糖苷酶和β-葡萄糖苷酶突变体及应用 | |
CN105002192B (zh) | 一种苹果酸酶基因rkme1及其重组表达载体 | |
CN102010869A (zh) | 一种腊梅胚胎发育晚期丰富蛋白的基因及其抗低温应用 | |
CN101492689A (zh) | 玉米c4型磷酸烯醇式丙酮酸羧化酶基因及其在小麦生产中的应用 | |
CN108424937B (zh) | 一种酶法合成丹参素的方法 | |
CN103849639B (zh) | 一种提高半胱氨酸利用率生物合成谷胱甘肽的方法 | |
CN105602880A (zh) | 一株谷氨酸棒杆菌及其过量合成磷脂酰丝氨酸的方法 | |
CN105349557B (zh) | 一种苹果酸酶基因rkme2及其重组表达载体 | |
CN105950596A (zh) | 一种双功能酸性脲酶基因及其表达与应用 | |
CN105624174A (zh) | 一种促进丙酮酸分泌的基因、其提取方法和应用 | |
CN103409437B (zh) | 一种促进乙酸分泌的溶磷基因 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20190419 Termination date: 20200222 |